Vincerx Pharma (VINC) Insider Trading & Ownership $0.04 -0.01 (-18.78%) As of 08/8/2025 03:45 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vincerx Pharma (NASDAQ:VINC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.60%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$112.36KNumber OfInsiders Selling(Last 3 Years)0 Get VINC Insider Trade Alerts Want to know when executives and insiders are buying or selling Vincerx Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VINC Insider Buying and Selling by Quarter Vincerx Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/11/2023Alexander A SeelenbergerInsiderBuy525$19.00$9,975.00 8/9/2023Ahmed Md HamdyInsiderBuy845$19.00$16,055.00 12/14/2022Ahmed Md HamdyCEOBuy1,764$17.40$30,693.60 12/14/2022Raquel E IzumiInsiderBuy1,436$17.60$25,273.60 8/24/2022Christopher P LoweDirectorBuy920$33.00$30,360.00 (Data available from 1/1/2013 forward) VINC Insider Trading Activity - Frequently Asked Questions Who is on Vincerx Pharma's Insider Roster? The list of insiders at Vincerx Pharma includes Ahmed Md Hamdy, Alexander A Seelenberger, Christopher P Lowe, and Raquel E Izumi. Learn more on insiders at VINC. What percentage of Vincerx Pharma stock is owned by insiders? 15.60% of Vincerx Pharma stock is owned by insiders. Learn more on VINC's insider holdings. Which Vincerx Pharma insiders have been buying company stock? The following insider purchased VINC shares in the last 24 months: Alexander A Seelenberger ($9,975.00). How much insider buying is happening at Vincerx Pharma? Insiders have purchased a total of 525 VINC shares in the last 24 months for a total of $9,975.00 bought. Vincerx Pharma Key ExecutivesDr. Ahmed M. Hamdy M.D. (Age 59)Co-Founder, Chairman & CEO Compensation: $657.54kDr. Raquel E. Izumi Ph.D. (Age 54)Co-Founder, President, COO, Secretary & Director Compensation: $591.54kMr. Alexander A. Seelenberger M.B.A. (Age 45)Chief Financial Officer Compensation: $491.69kMr. Tom C. Thomas J.D. (Age 64)Founder, General Counsel & Chief Legal Officer Compensation: $444.14kDr. John C. Byrd M.D.Founder & Chairman of Scientific Advisory BoardDr. Hans-Georg Lerchen Ph.D.Chief Scientific OfficerMs. Gabriela JairalaSr Executive Director of Investor Relations & Corporate CommunicationsMs. Karen QuarfordVice President of Quality Operations & ComplianceMs. Melissa Merrick SPHRSenior Director of People & Culture and Head of Human ResourceDr. Beatrix Stelte-Ludwig Ph.D.Executive Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Orgenesis Insider Ownership Hepion Pharmaceuticals Insider Ownership Viracta Therapeutics Insider Ownership MyMD Pharmaceuticals Insider Ownership Smart for Life Insider Ownership Syros Pharmaceuticals Insider Ownership Vaxxinity Insider Ownership Evelo Biosciences Insider Ownership Comera Life Sciences Insider Ownership Ampio Pharmaceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:VINC) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale